BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 32766925)

  • 1. Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia.
    Rios SJ; Martínez-Montesinos L; Aroca C; Teruel-Montoya R; Ferrer-Marín F
    J Assist Reprod Genet; 2020 Oct; 37(10):2473-2476. PubMed ID: 32766925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Level of CD8
    Kwaśnik P; Zaleska J; Link-Lenczowska D; Zawada M; Wysogląd H; Ochrem B; Bober G; Wasilewska E; Hus I; Szarejko M; Prejzner W; Grzybowska-Izydorczyk O; Klonowska-Szymczyk A; Mędraś E; Kiełbus M; Sacha T; Giannopoulos K
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia.
    Ureshino H; Kamachi K; Kimura S
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e138-e141. PubMed ID: 38195325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.
    Ross DM; Masszi T; Gómez Casares MT; Hellmann A; Stentoft J; Conneally E; Garcia-Gutierrez V; Gattermann N; le Coutre PD; Martino B; Saussele S; Giles FJ; Radich JP; Saglio G; Deng W; Krunic N; Bédoucha V; Gopalakrishna P; Hochhaus A
    J Cancer Res Clin Oncol; 2018 May; 144(5):945-954. PubMed ID: 29468438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis.
    Di Q; Deng H; Zhao Y; Li BY; Qin L
    Comput Math Methods Med; 2021; 2021():3110622. PubMed ID: 34956393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
    Flygt H; Söderlund S; Richter J; Saussele S; Koskenvesa P; Stenke L; Mustjoki S; Dimitrijevic A; Stentoft J; Majeed W; Roy L; Wolf D; Dreimane A; Gjertsen BT; Gedde-Dahl T; Ahlstrand E; Markevärn B; Hjorth-Hansen H; Janssen J; Olsson-Strömberg U
    Leukemia; 2024 Apr; 38(4):781-787. PubMed ID: 38278960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case Report of Kidney Transplantation in a Patient With Pre-existing Chronic Myeloid Leukemia: The Role of Achieving Molecular Response and Treatment-Free Remission.
    Pinlac V; Bonifacio L
    Transplant Proc; 2024 Apr; 56(3):738-741. PubMed ID: 38538381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for achieving treatment-free remission in chronic myeloid leukaemia.
    Saglio G; Gale RP
    Br J Haematol; 2020 Aug; 190(3):318-327. PubMed ID: 32057102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra".
    Abruzzese E; Trawinska MM; De Fabritiis P; Bernardi S
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):214-223. PubMed ID: 38151389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry.
    Chelysheva E; Apperley J; Turkina A; Yassin MA; Rea D; Nicolini FE; Barraco D; Kazakbaeva K; Saliev S; Abulafia AS; Al-Kindi S; Byrne J; Robertson HF; Cerrano M; Shmakov R; Polushkina E; de Fabritiis P; Trawinska MM; Abruzzese E
    Leukemia; 2024 Apr; 38(4):788-795. PubMed ID: 38388649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.
    Fujioka Y; Sugiyama D; Matsumura I; Minami Y; Miura M; Atsuta Y; Ohtake S; Kiyoi H; Miyazaki Y; Nishikawa H; Takahashi N
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
    Borghi L; Rosti G; Maggi A; Breccia M; Di Bona E; Iurlo A; La Barba G; Sportoletti P; Albano F; Galimberti S; Rivellini F; Cambrin GR; Capodanno I; Cuneo A; Bonifacio M; Sica S; Arcaini L; Capochiani E; Minotto C; Ciceri F; Crugnola M; Di Caprio L; Supekar S; Elena C; Baccarani M; Vegni E
    Front Oncol; 2021; 11():638689. PubMed ID: 34123791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CML.
    Millot F; Suttorp M; Ragot S; Leverger G; Dalle JH; Thomas C; Cheikh N; Nelken B; Poirée M; Plat G; Versluys B; Lausen B; Borisevich M
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models.
    Zad Z; Bonecker S; Wang T; Zalcberg I; Stelzer GT; Sabioni B; Gutiyama LM; Fleck JL; Paschalidis IC
    Leuk Res; 2024 Jun; 141():107502. PubMed ID: 38636414
    [No Abstract]   [Full Text] [Related]  

  • 15. The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort.
    Saugues S; Lambert C; Daguenet E; Roth-Guepin G; Huguet F; Cony-Makhoul P; Ansah HJ; Escoffre-Barbe M; Turhan A; Rousselot P; Tchirkov A; Hamroun D; Hermet E; Pereira B; Berger MG
    Haematologica; 2024 May; ():. PubMed ID: 38695126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Pregnancy and Delivery After Frozen-thawed Embryo Transfer Following the Third Discontinuation of Tyrosine Kinase Inhibitor in a Woman with Chronic Myeloid Leukemia.
    Takayama K; Fujisawa S; Sakuma T; Hasegawa K; Katsuki K; Akimoto M; Matsumura A; Nakajima Y; Miyazaki T; Murase M; Nakajima H
    Intern Med; 2024 Apr; ():. PubMed ID: 38599867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia.
    Braga AGO; Barbosa Pagnano KB; Campioni MDP; Lopes ABP; Duarte GO; Metze K; Lorand-Metze I
    Hematol Transfus Cell Ther; 2024; 46(3):268-272. PubMed ID: 37442648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.
    Nesr G; Claudiani S; Milojkovic D; Innes A; Fernando F; Caballes I; Mungozi P; Szydlo R; Lovato S; Jayasena C; Apperley J
    Leuk Lymphoma; 2024 Apr; ():1-6. PubMed ID: 38652865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.
    Robertson HF; Milojkovic D; Butt N; Byrne J; Claudiani S; Copland M; Gallipoli P; Innes AJ; Knight K; Mahdi AJ; Parker J; Virchis A; Apperley JF
    Br J Haematol; 2024 May; ():. PubMed ID: 38698705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms.
    Ferrer-Marín F; Cuenca-Zamora EJ; Guijarro-Carrillo PJ; Teruel-Montoya R
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.